Vice President, U.S. Market Access & Pricing

Vaxcyte, Inc

San Carlos (CA)

Hybrid

USD 333,000 - 388,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Vaxcyte, Inc is looking for a Vice President, U.S. Market Access & Pricing to shape market access strategy for their adult pneumococcal vaccine. This role is pivotal as the company prepares for its first commercial launch, requiring a strategic leader with extensive experience in pricing and access dynamics.

The ideal candidate will possess 15+ years in market access/biotech, demonstrating strong cross-functional skills across pricing and reimbursement.

Qualifications

  • 15+ years of experience in market access, pricing, or reimbursement within biotech/pharma.
  • Demonstrated experience leading product launches, ideally in vaccines.
  • Strong understanding of adult vaccine access dynamics and reimbursement processes.

Responsibilities

  • Lead U.S. market access strategy for the adult pneumococcal vaccine.
  • Shape access strategies across various payer channels.
  • Establish pricing strategy and ensure readiness for coding and coverage.

Skills

Market access strategy
Pricing and reimbursement
Stakeholder engagement

Education

Bachelor’s degree required; advanced degree preferred

Tools

Financial modeling

Job description

Vice President, U.S. Market Access & Pricing
Join our Mission to Protect Humankind!

Vaxcyte is a clinical‑stage vaccine innovation company engineering high‑fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well‑defined, and Vaxcyte is set up to go the distance.

The Vice President, Market Access will lead the strategy and execution of all market access activities to support the successful launch of the company’s adult pneumococcal vaccine. Reporting to the Chief Commercial Officer, this role will be accountable for ensuring broad, timely, and sustainable access across public and private channels.

As Vaxcyte prepares for its first commercial launch, the VP will operate as a hands‑on leader, building foundational capabilities while directly shaping payer, provider, and policy environments. This role requires a balance of strategic leadership and execution, with a particular focus on navigating the unique access dynamics of adult vaccines, including public health recommendations, buy‑and‑bill reimbursement, and site‑of‑care considerations.

Essential Functions
  • Lead development and execution of the U.S. market access strategy for the adult pneumococcal vaccine, including pricing, reimbursement, contracting, and channel strategy
  • Define and drive launch readiness plans aligned to regulatory approval and immunization guideline milestones (e.g., ACIP or other recommending bodies)
  • Shape access strategies across commercial payers, Medicare, Medicaid, and public health channels
  • Develop and execute engagement strategies for key stakeholders, including GPOs, IDNs, retail pharmacy, and public health entities
  • Establish pricing strategy and gross‑to‑net assumptions, ensuring alignment with vaccine‑specific market dynamics
  • Ensure readiness for coding, coverage, reimbursement, and provider economics within buy‑and‑bill and pharmacy settings
  • Partner with Medical Affairs to define and deliver HEOR and value evidence to support payer and policy decision‑making
  • Serve as the market access lead across cross‑functional teams, aligning with Commercial, Medical, Regulatory, Government Affairs, and Finance
  • Build and lead a lean market access function, leveraging external partners to scale capabilities efficiently
  • Working cross‑functionally, prepare for CDC immunization program, state immunization program, and ACIP‑adjacent policy stakeholder engagements; translate ACIP recommendation language into access and coverage implications across all channels
  • Develop and execute integrated PBM, commercial payer, and Medicare Part B and D contracting strategies to ensure optimal formulary positioning, coverage, and patient access across channels.
  • Support development of national retail pharmacy and alternate vaccination site strategies, establishing partnerships that maximize vaccine availability, administration, and uptake.
  • Develop scenario‑based access, reimbursement, and customer adoption strategies aligned to potential ACIP recommendation outcomes and evolving adult immunization guidelines
Requirements
  • Bachelor’s degree required; advanced degree (MBA, MPH, PharmD, PhD) preferred
  • 15+ years of experience in market access, pricing, reimbursement, or related functions within biotech/pharma
  • Demonstrated experience supporting or leading product launches, ideally in vaccines, infectious disease, or buy‑and‑bill products
  • Strong understanding of adult vaccine access dynamics, including public health recommendations, Medicare Part B and Part D reimbursement, Medicaid, 340B program implications, CDC contract vehicles (Section 317 and VFC), and site‑of‑care economics
  • Experience operating in lean or pre‑commercial biotech environments, with a demonstrated track record of building market access capabilities from the ground up
  • Proven ability to balance strategic thinking with hands‑on execution
  • Strong cross‑functional leadership and stakeholder influence skills
  • Experience managing gross‑to‑net financial modelling, including rebate strategy across payers
  • Demonstrated ability to work collaboratively with HEOR teams to translate cost‑effectiveness models, budget impact analyses, and payer value dossiers into P&T committee submissions or ICER reviews
  • Prior engagement with CDC immunization programs, state immunization programs, or ACIP‑adjacent policy processes; understanding of how ACIP recommendation language drives uptake across channels

Reports to: Chief Commercial Officer

Location: East Coast - US

Work Arrangement: Hybrid (minimum of 2-3 days per week) / Remote

Compensation:

The compensation package will be competitive and includes comprehensive benefits and an equity component.

Salary Range: $333,000 - $388,000 (SF Bay Area). Salary ranges for non‑California locations may vary.

Relocation:

This role is eligible for relocation assistance.

We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Vice President, Insights & Analytics
Vice President, Insights & Analytics

Vaxcyte • San Carlos (CA)

Hybrid
USD 325,000 - 385,000
Equity component
Comprehensive benefits
Vice President, Insights & Analytics
Vice President, Insights & Analytics

Vaxcyte, Inc. • San Diego (CA)

Hybrid
USD 325,000 - 385,000
Vice President, Insights & Analytics
Vice President, Insights & Analytics

Vaxcyte • Philadelphia

Hybrid
USD 325,000 - 385,000
Comprehensive benefits
Equity component
Executive Director, Digital Enablement
Executive Director, Digital Enablement

Vaxcyte • United States

Remote
USD 288,000 - 335,000
Relocation assistance
Equity component
Comprehensive benefits
VP, U.S. Vaccine Market Access & Pricing
VP, U.S. Vaccine Market Access & Pricing

Vaxcyte, Inc • San Carlos (CA)

Hybrid
USD 333,000 - 388,000
Vice President, Vaccines Sales
Vice President, Vaccines Sales

Pfizer Inc • New York (NY)

On-site
USD 300,000 - 500,000
Vice President, Vaccines Sales
Vice President, Vaccines Sales

Pfizer Inc • Pennsylvania

On-site
USD 300,000 - 500,000
401(k) plan with company matching
Comprehensive benefits (medical, Rx, d
Paid vacation/holidays/personal days
+1
Vice President, Vaccines Sales
Vice President, Vaccines Sales

Pfizer Inc • Collegeville (PA)

On-site
USD 300,000 - 500,000
Director Market Access
Director Market Access

Caraway Therapeutics, Inc. • United States

Hybrid
USD 191,000 - 300,000
Medical insurance
Dental insurance
Vision insurance
+2
Director Market Access
Director Market Access

1000 Merck Sharp & Dohme LLC • North Wales

On-site
USD 191,000 - 300,000